8 terminated. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Terminated 8 |
Follow Haloperidol: new trials by email Literature Review of Haloperidol trials Research Report on Haloperidol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis Droperidol, Haloperidol, Ondansetron 8mg - Cyclic Vomiting Syndrome | Phase 3 | Terminated | Corewell Health South | 32 | 2021-08-30 | 2025-05-21 |
| Haloperidol for Delirium in Adult Critically Ill Patients Haloperidol, Placebo - Delirium, Critical Illness | Phase 3 | Terminated | Erasmus Medical Center | 142 | 2018-02-22 | 2022-05-11 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| Dexmedetomidine for the Treatment of Delirium After Heart Surgery Dexmedetomidine, Haloperidol, Saline - Postoperative, Delirium | Phase 3 | Terminated | Thorax-Kärlkliniken | 3 | 2010-05-01 | 2016-11-01 |
| A Double-blind, Randomized, Controlled Trial of Quetiapine Versus Haloperidol for the Treatment of Delirium quetiapine, haloperidol - Delirium | Phase 3 | Terminated | Chiang Mai University | 52 | 2009-06-01 | 2011-06-23 |
| Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients Haloperidol, Methylphenidate, Rivastigmine - Delirium | Phase 3 | Terminated | UMC Utrecht | 80 | 2008-02-01 | 2018-03-21 |
| ORIC-I: Optimizing Recovery From Intensive Care: Mechanical Ventilation and Delirium haloperidol, Saline placebo - Delirium | Phase 3 | Terminated | University of Pittsburgh | 40 | 2006-03-01 | 2017-12-20 |
| Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer Olanzapine, Haldol - Nausea, Neoplasms | Phase 3 | Terminated | Alberta Health services | 80 | 2005-05-01 | 2012-01-19 |
Delirium (5) · Anxiety Disorders (1) · Cognitive Dysfunction (1) · Confusion (1) · Critical Illness (1) · Dementia (1) · Depression (1) · Familial cyclic vomiting syndrome (1) · Nausea (1) · Neoplasms (1) · Psychophysiologic Disorders (1) · Schizophrenia (1)
Alberta Health services (1) · Chiang Mai University (1) · Corewell Health South (1) · Erasmus Medical Center (1) · Hannover Medical School (1) · Thorax-Kärlkliniken (1) · UMC Utrecht (1) · University of Pittsburgh (1)
Netherlands (2) · Canada (1) · Germany (1) · Sweden (1) · Thailand (1) · United States (1)
Benchalak Maneeton, Assoc Prof (1) · Eric B Milbrandt, MD, MPH (1) · Helge Frieling, Prof., MD (1) · Jose Pereira (1) · Jozef Kesecioglu, MD PhD (1) · Mathieu van der Jagt, MD PhD (1) · Sten M Walther, MD PhD (1)
PMID 18041437, PMID 23926422, PMID 32967873, PMID 37904241
K23HL078760 (1)